SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS
Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) an...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KOHR, SILKE HAENDLER, BERNARD FAUS GIMENEZ, HORTENSIA CLEVE, ARWED LUCKING, ULRICH IRLBACHER, HORST |
description | Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ598643A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ598643A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ598643A3</originalsourceid><addsrcrecordid>eNrjZHAKDg0O8QwJDXF1UdBQ8HANcQ3ydwyK9PF1DfGI9FHQVAjx8PT3iHRx9Avx9_QLVnAEIr8QT2dHP2fXIAWXoFD3YB4G1rTEnOJUXijNzSDn5hri7KGbWpAfn1pckJicmpdaEu8XZWppYWZi7GhMUAEAMOMqfg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><source>esp@cenet</source><creator>KOHR, SILKE ; HAENDLER, BERNARD ; FAUS GIMENEZ, HORTENSIA ; CLEVE, ARWED ; LUCKING, ULRICH ; IRLBACHER, HORST</creator><creatorcontrib>KOHR, SILKE ; HAENDLER, BERNARD ; FAUS GIMENEZ, HORTENSIA ; CLEVE, ARWED ; LUCKING, ULRICH ; IRLBACHER, HORST</creatorcontrib><description>Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131025&DB=EPODOC&CC=NZ&NR=598643A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131025&DB=EPODOC&CC=NZ&NR=598643A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOHR, SILKE</creatorcontrib><creatorcontrib>HAENDLER, BERNARD</creatorcontrib><creatorcontrib>FAUS GIMENEZ, HORTENSIA</creatorcontrib><creatorcontrib>CLEVE, ARWED</creatorcontrib><creatorcontrib>LUCKING, ULRICH</creatorcontrib><creatorcontrib>IRLBACHER, HORST</creatorcontrib><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><description>Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAKDg0O8QwJDXF1UdBQ8HANcQ3ydwyK9PF1DfGI9FHQVAjx8PT3iHRx9Avx9_QLVnAEIr8QT2dHP2fXIAWXoFD3YB4G1rTEnOJUXijNzSDn5hri7KGbWpAfn1pckJicmpdaEu8XZWppYWZi7GhMUAEAMOMqfg</recordid><startdate>20131025</startdate><enddate>20131025</enddate><creator>KOHR, SILKE</creator><creator>HAENDLER, BERNARD</creator><creator>FAUS GIMENEZ, HORTENSIA</creator><creator>CLEVE, ARWED</creator><creator>LUCKING, ULRICH</creator><creator>IRLBACHER, HORST</creator><scope>EVB</scope></search><sort><creationdate>20131025</creationdate><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><author>KOHR, SILKE ; HAENDLER, BERNARD ; FAUS GIMENEZ, HORTENSIA ; CLEVE, ARWED ; LUCKING, ULRICH ; IRLBACHER, HORST</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ598643A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOHR, SILKE</creatorcontrib><creatorcontrib>HAENDLER, BERNARD</creatorcontrib><creatorcontrib>FAUS GIMENEZ, HORTENSIA</creatorcontrib><creatorcontrib>CLEVE, ARWED</creatorcontrib><creatorcontrib>LUCKING, ULRICH</creatorcontrib><creatorcontrib>IRLBACHER, HORST</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOHR, SILKE</au><au>HAENDLER, BERNARD</au><au>FAUS GIMENEZ, HORTENSIA</au><au>CLEVE, ARWED</au><au>LUCKING, ULRICH</au><au>IRLBACHER, HORST</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS</title><date>2013-10-25</date><risdate>2013</risdate><abstract>Disclosed herein is a thiohydantoin compound of formula (I) wherein the variables are defined in the specification, a method for the preparation thereof involving the reaction of an isothiocyanate intermediate with a nitrile intermediate which is then hydrolysed to yield a compound of formula (I) and optionally reacted with the corresponding solvents and/or bases or acids to the solvates, salts and/or solvates of the salts thereof, for use in the treatment of a prostate cancer. Exemplary compounds include: 4-(3-{ [6-(1H-imidazol-1-yl)pyridin-3-yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile; 4-(4,4-dimethyl-3-{ [ 6-(2-methylmorpholin-4-yl)pyridin-3 -yl] methyl} -5-oxo-2-thioxoimidazolidin-l-yl)-2-(trifluoromethyl)benzonitrile; and 4-(3-{ [6-(2-methoxyethoxy)pyridin-3 -yl]methyl} -4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_NZ598643A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | SUSTITUTED ( HETEROARYLMETHYL ) THIOHYDANTOINS AS ANTICANCER DRUGS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOHR,%20SILKE&rft.date=2013-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ598643A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |